Kingswood Wealth Advisors LLC Purchases 13,579 Shares of GE HealthCare Technologies Inc. $GEHC

Kingswood Wealth Advisors LLC raised its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 298.5% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 18,128 shares of the company’s stock after acquiring an additional 13,579 shares during the quarter. Kingswood Wealth Advisors LLC’s holdings in GE HealthCare Technologies were worth $1,487,000 at the end of the most recent quarter.

A number of other institutional investors also recently bought and sold shares of the company. Temasek Holdings Private Ltd bought a new position in shares of GE HealthCare Technologies in the third quarter worth about $99,922,000. Valicenti Advisory Services Inc. raised its stake in shares of GE HealthCare Technologies by 22.6% in the third quarter. Valicenti Advisory Services Inc. now owns 68,107 shares of the company’s stock worth $5,115,000 after buying an additional 12,550 shares during the period. Locust Wood Capital Advisers LLC raised its stake in shares of GE HealthCare Technologies by 7.1% in the third quarter. Locust Wood Capital Advisers LLC now owns 2,084,337 shares of the company’s stock worth $156,534,000 after buying an additional 137,992 shares during the period. Nan Fung Trinity HK Ltd. bought a new position in shares of GE HealthCare Technologies in the third quarter worth about $23,206,000. Finally, Envestnet Asset Management Inc. raised its stake in shares of GE HealthCare Technologies by 15.8% in the third quarter. Envestnet Asset Management Inc. now owns 338,914 shares of the company’s stock worth $25,452,000 after buying an additional 46,231 shares during the period. Institutional investors own 82.06% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on the company. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of GE HealthCare Technologies in a research note on Monday, December 29th. The Goldman Sachs Group decreased their price objective on GE HealthCare Technologies from $97.00 to $81.00 and set a “buy” rating on the stock in a research note on Thursday, April 9th. Morgan Stanley raised their price objective on GE HealthCare Technologies from $80.00 to $85.00 and gave the stock an “equal weight” rating in a research note on Wednesday, February 4th. Citigroup decreased their price objective on GE HealthCare Technologies from $88.00 to $84.00 and set a “neutral” rating on the stock in a research note on Wednesday, March 11th. Finally, Mizuho cut their target price on GE HealthCare Technologies from $95.00 to $90.00 and set an “outperform” rating for the company in a research report on Monday, April 13th. Eight research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $89.77.

GE HealthCare Technologies Price Performance

Shares of GE HealthCare Technologies stock opened at $69.89 on Friday. The stock has a market cap of $31.89 billion, a price-to-earnings ratio of 15.33, a price-to-earnings-growth ratio of 1.57 and a beta of 1.17. The company has a debt-to-equity ratio of 0.91, a quick ratio of 1.13 and a current ratio of 1.37. The stock has a 50 day moving average price of $74.88 and a 200-day moving average price of $77.82. GE HealthCare Technologies Inc. has a one year low of $64.77 and a one year high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Wednesday, February 4th. The company reported $1.44 EPS for the quarter, topping analysts’ consensus estimates of $1.40 by $0.04. The firm had revenue of $5.70 billion during the quarter, compared to analysts’ expectations of $5.60 billion. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The company’s quarterly revenue was up 7.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.45 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Equities analysts expect that GE HealthCare Technologies Inc. will post 5 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Friday, April 3rd will be issued a $0.035 dividend. The ex-dividend date is Thursday, April 2nd. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s payout ratio is 3.07%.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.